Wei Chen - Avepoint Head Development
| AVPT Stock | USD 18.12 0.10 0.55% |
Executive
Wei Chen is Head Development of Avepoint
| Address | 525 Washington Boulevard, Jersey City, NJ, United States, 07310 |
| Phone | 201 793 1111 |
| Web | https://www.avepoint.com |
Wei Chen Latest Insider Activity
Tracking and analyzing the buying and selling activities of Wei Chen against Avepoint stock is an integral part of due diligence when investing in Avepoint. Wei Chen insider activity provides valuable insight into whether Avepoint is net buyers or sellers over its current business cycle. Note, Avepoint insiders must abide by specific rules, including filing SEC forms every time they buy or sell Avepoint'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Wei Chen over a year ago Acquisition or disposition of EUDA Health securities by Wei Chen | ||
Wei Chen over a year ago EUDA Health exotic insider transaction detected |
Avepoint Management Efficiency
Return On Tangible Assets is likely to drop to -0.06 in 2024. Return On Capital Employed is likely to drop to -0.06 in 2024. Non Current Liabilities Other is likely to gain to about 24.3 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 115.1 M in 2024. Avepoint's management efficiency ratios could be used to measure how well Avepoint manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Pedro Zinner | StoneCo | 49 | |
| Suzanne DuLong | F5 Networks | N/A | |
| Munil Shah | Uipath Inc | N/A | |
| Sammy Zoghlami | Nutanix | N/A | |
| Barbara Larson | SentinelOne | 53 | |
| Kevin Kane | CCC Intelligent Solutions | N/A | |
| Matthew DuBois | Cloudflare | N/A | |
| Scott Alexander | Arqit Quantum | N/A | |
| Brian Martin | Nutanix | 62 | |
| Dave Gwyn | Nutanix | N/A | |
| Jon Herstein | Box Inc | N/A | |
| Kimberly Bloomston | Liveramp Holdings | 41 | |
| David Webb | Arqit Quantum | N/A | |
| Brian Schipper | Yext Inc | 63 | |
| David JD | Box Inc | N/A | |
| Tonya Chin | Nutanix | N/A | |
| Olivia Nottebohm | Box Inc | 46 | |
| Matthew Young | Nutanix | N/A | |
| Hitesh Ramani | Uipath Inc | N/A | |
| Jennifer Lepird | Nutanix | N/A | |
| Patrick Willcocks | Arqit Quantum | 56 | |
Management Performance
| Return On Equity | -0.035 | ||||
| Return On Asset | 0.0046 |
Avepoint Leadership Team
Elected by the shareholders, the Avepoint's board of directors comprises two types of representatives: Avepoint inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avepoint. The board's role is to monitor Avepoint's management team and ensure that shareholders' interests are well served. Avepoint's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avepoint's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nicole Caci, Public Manager | ||
| John Peluso, Chief Officer | ||
| Tianyi Jiang, CEO CoFounder | ||
| Clara Lim, Chief Officer | ||
| James CPA, Chief Officer | ||
| Sophia Wu, Chief Officer | ||
| Dux Sy, Chief Officer | ||
| Brian Brown, Secretary Officer | ||
| Stuart Robertson, Chief Officer | ||
| JD Cipp, Privacy Risk | ||
| Wei Chen, Head Development | ||
| Cipp JD, Privacy Risk | ||
| Mario Carvajal, Chief Officer | ||
| Xunkai Gong, Cofounder Chairman | ||
| James Caci, Chief Officer | ||
| James Arestia, Vice Relations | ||
| Brian JD, Secretary Officer |
Avepoint Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avepoint a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.035 | ||||
| Return On Asset | 0.0046 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 3.18 B | ||||
| Shares Outstanding | 187.51 M | ||||
| Shares Owned By Insiders | 36.62 % | ||||
| Shares Owned By Institutions | 49.38 % | ||||
| Number Of Shares Shorted | 4.81 M | ||||
| Price To Book | 15.98 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avepoint Stock Analysis
When running Avepoint's price analysis, check to measure Avepoint's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avepoint is operating at the current time. Most of Avepoint's value examination focuses on studying past and present price action to predict the probability of Avepoint's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avepoint's price. Additionally, you may evaluate how the addition of Avepoint to your portfolios can decrease your overall portfolio volatility.